These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31602219)

  • 21. Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network.
    Lou W; Ding B; Xu L; Fan W
    Front Mol Neurosci; 2019; 12():66. PubMed ID: 30971889
    [No Abstract]   [Full Text] [Related]  

  • 22. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of core genes and potential molecular mechanisms in breast cancer using bioinformatics analysis.
    Liu F; Wu Y; Mi Y; Gu L; Sang M; Geng C
    Pathol Res Pract; 2019 Jul; 215(7):152436. PubMed ID: 31076281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis.
    Cheng C; Hua J; Tan J; Qian W; Zhang L; Hou X
    Exp Ther Med; 2019 Jul; 18(1):278-288. PubMed ID: 31258663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis.
    Alshabi AM; Vastrad B; Shaikh IA; Vastrad C
    Biomolecules; 2019 May; 9(5):. PubMed ID: 31137733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis.
    Feng H; Gu ZY; Li Q; Liu QH; Yang XY; Zhang JJ
    J Ovarian Res; 2019 Apr; 12(1):35. PubMed ID: 31010415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening the Significant Hub Genes by Comparing Tumor Cells, Normoxic and Hypoxic Glioblastoma Stem-like Cell Lines Using Co-Expression Analysis in Glioblastoma.
    Güven E; Afzal M; Kazmi I
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of key candidate genes and pathways in hepatocellular carcinoma by integrated bioinformatical analysis.
    Xing T; Yan T; Zhou Q
    Exp Ther Med; 2018 Jun; 15(6):4932-4942. PubMed ID: 29805517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.
    Zhu HM; Fei Q; Qian LX; Liu BL; He X; Yin L
    Oncol Lett; 2019 May; 17(5):4683-4694. PubMed ID: 30988824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of key genes and pathways at the downstream of S100PBP in pancreatic cancer cells by integrated bioinformatical analysis.
    Lu YJ; Yang Y; Hu TH; Duan WM
    Transl Cancer Res; 2021 Feb; 10(2):806-816. PubMed ID: 35116411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated bioinformatics analysis reveals novel hub genes closely associated with pathological mechanisms of immunoglobulin A nephropathy.
    Zhang D; Cao Y; Zuo Y; Wang Z; Mi X; Tang W
    Exp Ther Med; 2019 Aug; 18(2):1235-1245. PubMed ID: 31316619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of candidate genes associated with the pathogenesis of small cell lung cancer via integrated bioinformatics analysis.
    Liao Y; Yin G; Wang X; Zhong P; Fan X; Huang C
    Oncol Lett; 2019 Oct; 18(4):3723-3733. PubMed ID: 31516585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
    Wang W; Wang S; Pan L
    Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma.
    Cui H; Xu L; Li Z; Hou KZ; Che XF; Liu BF; Liu YP; Qu XJ
    Oncol Lett; 2020 Aug; 20(2):1573-1584. PubMed ID: 32724399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of key pathways and genes in endometrial cancer using bioinformatics analyses.
    Liu Y; Hua T; Chi S; Wang H
    Oncol Lett; 2019 Jan; 17(1):897-906. PubMed ID: 30655845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.